Jeffrey L. Wade

2009

In 2009, Jeffrey L. Wade earned a total compensation of $908.7K as Executive Vice President, Corporate Development and Chief Financial Officer at Lexicon Pharmaceuticals, a 40% increase compared to previous year.

Compensation breakdown

Bonus$90,000
Option Awards$407,063
Salary$340,000
Stock Awards$64,960
Other$6,696
Total$908,719

Wade received $407.1K in option awards, accounting for 45% of the total pay in 2009.

Wade also received $90K in bonus, $340K in salary, $65K in stock awards and $6.7K in other compensation.

Rankings

In 2009, Jeffrey L. Wade's compensation ranked 4,781st out of 9,885 executives tracked by ExecPay. In other words, Wade earned more than 51.6% of executives.

ClassificationRankingPercentile
All
4,781
out of 9,885
52nd
Division
Manufacturing
1,709
out of 3,690
54th
Major group
Chemicals And Allied Products
345
out of 871
60th
Industry group
Drugs
213
out of 643
67th
Industry
Pharmaceutical Preparations
162
out of 446
64th
Source: SEC filing on March 16, 2012.

Wade's colleagues

We found five more compensation records of executives who worked with Jeffrey L. Wade at Lexicon Pharmaceuticals in 2009.

2009

Arthur Sands

Lexicon Pharmaceuticals

Chief Executive Officer

2009

Brian Zambrowicz

Lexicon Pharmaceuticals

Chief Scientific Officer

2009

Alan Main

Lexicon Pharmaceuticals

Executive Vice President of Pharmaceutical Research

2009

Ajay Bansal

Lexicon Pharmaceuticals

Chief Financial Officer

2009

James Tessmer

Lexicon Pharmaceuticals

Vice President, Finance and Accounting

News

You may also like